1. Schäffer D, Stöver H, Weichert L. Drug consumption rooms in Europe models, best practice and challenges. 2014;1–19.
2. Hedrich D, Kerr T, Dubois-Arber F. Chap 11: drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. EMCDDA monographs harm reduction: evidence, impacts and challenges. Luxembourg: European Monitoring Centre for Drugs and Addiction; 2010. p. 305–31.
3. EMCDDA. Drug consumption rooms: an overview of provision and evidence. 2015.
4. Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A. Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction. 2009;104:614–9.
5. DeBeck K, Kerr T, Bird L, Zhang R, Marsh D, Tyndall M, Montaner J, Wood E. Injection drug use cessation and use of North America’s first medically supervised safer injecting facility. Drug Alcohol Depend. 2011;113(2–3):172–6.